You are here

Lexington Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LNB
CSE Index: 
Currency: 

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.

You are here

Lexington Biosciences Inc. (LNB)

SEDAR Information

Company Info

Address
1055 West Hastings Street
Suite 1900
Vancouver, BC V6E 2E9
Canada
Phone
(800) 320-2640
Email
info@lexingtonbiosciences.com
Listing date
Tuesday, May 9, 2017
Transfer Agent
AST Trust Company (Canada)

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
37,853,401
Reserved for Issuance: 
3,227,400

Bulletins

05/05/2017

2017-0507 - New Listing - Lexington Biosciences Inc. (LNB)

May 5, 2017

The common shares of Lexington Biosciences Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

12_11_13th_MA_Forum_Website

Into the Future – Emerging Tech Conference

Friday, December 14, 2018 -
9:00am to 3:00pm
01_10_New_Year_Kick_Off_2019_Website

New Year Kickoff 2019

Thursday, January 10, 2019 -
6:00pm to 11:00pm
01_15_Benzinga_Cannabis_Capital_Conference_Website

Benzinga Cannabis Capital Conference

Tuesday, January 15, 2019 (All day) to Wednesday, January 16, 2019 (All day)